RBC Capital Reaffirms Their Buy Rating on Maravai Lifesciences Holdings (MRVI)
RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...
bovnews13h
Maravai Lifesciences Holdings Inc (MRVI) Stock Rated Neutral by Guggenheim
Notable insider trades include ORESHACK KURT, General Counsel at Maravai Lifesciences Holdings Inc (MRVI), who sold 25000 shares on Jan 31 ’25, at $5.03 each, totaling $0.13 million. On May 28 ’24, ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Amgen (AMGN) and IQVIA Holdings (IQV)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX – Research Report), Amgen (AMGN – ...
Zacks.com on MSN8h
Envista (NVST) Beats Q4 Earnings and Revenue Estimates
Envista (NVST) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.29 per share a year ago. These figures are ...